Virus that Infects Bacteria Turns Immune Response Away from P. aeruginosa, Study Shows
Pseudomonas aeruginosa, the most common bacteria found in cystic fibrosis (CF) patients, uses a virus to go unnoticed by the host immune...
Symdeko Approved in Australia for CF Patients Age 12 or Older With Certain Gene Mutations
Cystic fibrosis (CF) patients in Australia age 12 and older, who have two copies of the F508del mutation in the CFTR gene (a copy...
Amphotericin B improves cystic fibrosis symptoms in cultured cells and pigs Antifungal drug forms io
An antifungal small molecule drug could restore some of the function lost in cystic fibrosis. Cystic fibrosis is a disease caused by...
Lung Enzyme Cathepsin S is New Therapeutic Target for CF and COPD
Blocking the enzyme cathepsin S can alleviate symptoms and reduce lung damage in cystic fibrosis (CF) and chronic obstructive pulmonary...
Gene Therapy
Cystic fibrosis (CF) is a rare, heritable disease caused by mutations in the CFTR gene, which provides instructions for making the CFTR...
Genetic Counseling
Cystic fibrosis (CF) is a genetic disease caused by mutations in the CFTRgene resulting in the buildup of thick, sticky mucus in various...
Hyperbaric Oxygen Treatment May Make Antiobiotics More Effective Against P. aeruginosa Infections, S
Exposing cystic fibrosis (CF) patients to high levels of oxygen through hyperbaric oxygen treatment may make Pseudomonas aeruginosa...
New Gene Therapy Strategy May Reverse Effects of Disease-related Mutations, Study Shows
A new strategy to genetically prevent disease-related mutations from occurring shows the potential to treat several genetic diseases,...
Paying more attention to antibiotic dosing could improve clinical outcomes for CF patients
Download PDF Copy Children and young adults with cystic fibrosis (CF) whose lung infections were treated with suboptimal doses of...
Savara Provides Update on IMPALA and AVAIL Pivotal Clinical Studies
AUSTIN, Texas, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today provided an update on...
